Valion Bio Terminates CEO, Expands CFO Role to COO
Valion Bio disclosed that Michael K. Handley was terminated as chief executive officer effective August 16, 2026. On the same date, Lisa Wolf was appointed chief operating officer while retaining her chief financial officer…
